Monday, August 30, 2010
Sanofi Offers $18.5 Billion for Genzyme - NYTimes.com
Sanofi Offers $18.5 Billion for Genzyme - NYTimes.com: "- Sent using Google Toolbar"
Subscribe to:
Post Comments (Atom)
Most Popular Posts
-
We posted previously, extensively and definitey about the need to limit biotechnology patents at In re Kubin : Hitting the NAIL on the Head ...
-
The Spread of Superbugs by Nicholas D. Kristof, March 7, 2010, at the New York Times Mobile "A study by the Union of Concerned Scientis...
-
It is often claimed that the liberal granting of patents is essential for the development of the pharmaceutical industry, especially modern ...
-
Text below crossposted from LawPundit . BRAVO to the United States Supreme Court! The unanimous (who would have believed that!) U.S. Supr...
-
Stephen Albainy-Jenei at the blog Patent Baristas has an extensive posting on In re Kubin at Court: It’s Not An Invention If You Use Conven...
No comments:
Post a Comment